Andrés Wigdorovitz

Andrés Wigdorovitz

Auto-generated profile, based on publicly available information

Andrés Wigdorovitz

Bioinnovo SA Hurlingham, Buenos Aires Argentina

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 December 2020 in Transboundary and Emerging Diseases
Verified
Journal Article
Closed access
PDF file
DBDemian Bellido
Demian Bellido
JBJosefina Baztarrica
Josefina Baztarrica
LRLucía Rocha
Lucía Rocha
APAndrea Pecora
Andrea Pecora
MAMario Acosta
Mario Acosta
AWAndrés Wigdorovitz
Andrés Wigdorovitz
Bovine viral diarrhea virus (BVDV) is a major cause of economic loss in the cattle industry, worldwide. Infection results in reduced productive performance, growth retardation, reduced milk production, and increased susceptibility to other diseases leading to early culling of animals. There are two primary methods used to control the spread of BVDV: the elimination of persistently infected (PI) animals and vaccination. Currently, modified live or inactivated vaccines are used in BVDV vaccination programs, but there are safety risks or insufficient protection, respectively, with these vaccines. Here we report the development and efficacy of the first targeted subunit vaccine against BVDV. The core of the vaccine is the fusion of the BVDV structural protein, E2, to a single‐chain antibody, APCH, together termed, APCH‐E2. The APCH antibody targets the E2 antigen to the major histocompatibility type II molecule (MHC‐II) present on antigen‐presenting cells. Industrial production of the vaccine is carried out using the baculovirus expression vector system (BEVS) using single‐use manufacturing technologies. This new subunit vaccine induces strong BVDV‐specific neutralizing antibodies in guinea pigs and cattle. Importantly, in cattle with low levels of natural BVDV‐specific neutralizing antibodies, the vaccine induced strong neutralizing antibody levels to above the protective threshold, as determined by a competition ELISA. The APCH‐E2 vaccine induced a rapid and sustained neutralizing antibody response compared to a conventional vaccine in cattle.

1 November 2016 in Journal of Virological Methods
Verified
Journal Article
Closed access
SCSofia Costa
Sofia Costa
PSPatricia Sastre
Patricia Sastre
TPTeresa Pérez
Teresa Pérez
ITIstar Tapia
Istar Tapia
MBMaría Barrandeguy
María Barrandeguy
PRPaloma Rueda
Paloma Rueda